Breaking News Instant updates and real-time market news.

SDC

SmileDirectClub

$10.56

-0.54 (-4.86%)

10:20
10/14/19
10/14
10:20
10/14/19
10:20

SmileDirectClub may or may not be hurt from AB-1519, says Stifel

The Governor of California on Sunday signed AB-1519, which extends the Dental Board's authority to oversee dental services until 2024, Stifel analyst Jonathan Block tells investors in a research note. The bill includes many amendments including several specific to self-applied orthodontic treatments administered via telehealth, and notes that the Dentist must review diagnostic digital or conventional radiographs for orthodontia prior to moving teeth, adds the analyst. Block says the headwinds the bill may or may not cause for SmileDirectClub's business are "difficult to decipher." He adds, though, that he called out AB-1519 in his initiation report as potentially causing multiple compression in the near-term. The analyst keeps a Buy rating on SmileDirectClub with a $19 price target. The stock in morning trading is down 5%, or 57c, to $10.56.

  • 12

    Nov

SDC SmileDirectClub
$10.56

-0.54 (-4.86%)

10/07/19
SBSH
10/07/19
INITIATION
Target $19
SBSH
Buy
SmileDirectClub initiated with a Buy rating at Citi
Citi analyst Stephanie Demko initiated coverage of SmileDirectClub with a Buy rating and $19 price target, citing her view that its unique vertically integrated, direct-to-consumer approach should fuel top quartile growth and margin expansion. She attributes the stock's "valuation disconnect" to short-term execution issues and sees the current trading levels of the stock presenting a "unique" entry point, Demko added.
10/07/19
LOOP
10/07/19
INITIATION
Target $20
LOOP
Buy
SmileDirectClub initiated with a Buy at Loop Capital
Loop Capital analyst Laura Champine initiated SmileDirectClub with a Buy rating and price target of $20. The analyst notes that the company's value and convenience offered to customers is "unmatched" and believes that it will continue capturing market share. Champine adds that SmileDirectClub's planned shift of manufacturing to in-house this year will reduce its costs, limit risk, and boost its potential for greater scale over time.
10/07/19
WBLR
10/07/19
INITIATION
WBLR
Outperform
William Blair calls SmileDirectClub next big growth story in dental
William Blair analyst John Kreger initiated coverage of SmileDirectClub with an Outperform rating. The analyst views the stock as a "compelling choice for investors seeking high growth and willing to tolerate higher volatility." He sees SmileDirectClub as the next big growth story in the dental space as the clear aligner market expands. The comany's shipment growth exceeded 100% last year and Kreger expects it to grow 75% in 2019 and at a 40% compound annual rate through 2023.
10/07/19
10/07/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. SmileDirectClub (SDC) initiated with an Outperform at Credit Suisse and William Blair, an Overweight rating at JPMorgan, and a Buy at Loop Capital, Citi, Jefferies, BTIG, Guggenheim, BofA/Merrill, and Stifel. 2. SJW Corp. (SJW) initiated with an Outperform rating at Macquarie. 3. FleetCor (FLT) initiated with a Sector Perform at RBC Capital. 4. Gladstone Land (LAND) initiated with a Buy rating at Aegis. 5. Sutro Biopharma (STRO) initiated with a Buy at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:13
11/12/19
11/12
08:13
11/12/19
08:13
Hot Stocks
scPharmaceuticals expects 2019 cash, cash equivalents $65M-$70M »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Earnings
scPharmaceuticals reports Q3 EPS (31c), consensus (45c) »

"We continue to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Hot Stocks
Amarin jumps as FDA posts documents for Vascepa advisory committee meeting »

Shares of Amarin (AMRN)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Downgrade
Cellular Biomedicine rating change  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCNX

Vaccinex

$5.05

0.19 (3.91%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Earnings
Vaccinex reports Q3 revenue $404,000, consensus 30,000 »

"The highlight of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

, BIOX

Bioceres

$5.70

-0.2 (-3.39%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Verdeca receives approval of HB4 drought and herbicide tolerant soybeans »

Verdeca, a joint venture…

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

BIOX

Bioceres

$5.70

-0.2 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$0.70

0.008 (1.16%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
NantHealth reports FDA marketing authorization of Omics Core »

NantHealth reported FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Amarin soars after FDA posts briefing docs ahead of Nov. 14 panel »

Shares of Amarin are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

SWTX

SpringsWorks Therapeutics

$18.42

-0.1 (-0.54%)

08:10
11/12/19
11/12
08:10
11/12/19
08:10
Earnings
SpringsWorks Therapeutics reports Q3 EPS ($1.77), consensus (47c) »

"The third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNE

Clean Energy

$2.23

-0.01 (-0.45%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Earnings
Clean Energy reports Q3 EPS (2c), consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HON

Honeywell

$180.73

-0.48 (-0.26%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Honeywell Process Solutions selected by Kuwait Integrated Petroleum Industries »

Honeywell announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Cellectar Biosciences expects cash to fund operations into 1Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Earnings
Cellectar Biosciences reports Q3 EPS (42c), consensus (38c) »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.05

-0.02 (-1.87%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Hot Stocks
Moleculin Biotech receives FDA approval for IND of WP1066 »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Hot Stocks
LogicBio Therapeutics expects cash to fund operations into 2021 »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Earnings
LogicBio Therapeutics reports Q3 EPS (48c), consensus (46c) »

"This has been a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin jumps 7% to $18.13…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

MPAA

Motorcar Parts

$19.96

-0.66 (-3.20%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Earnings
Motorcar Parts reports Q2 adj. EPS 68c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FATE

Fate Therapeutics

$14.49

-0.09 (-0.62%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Initiation
Fate Therapeutics initiated  »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$38.33

0.17 (0.45%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Legg Mason reports AUM of $791.0B as of October 31 »

Legg Mason reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$39.21

1.09 (2.86%)

, VIA

Viacom

$26.40

0.87 (3.41%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
CBS, Viacom merger expected to close in early December »

On August 13, CBS (CBS)…

CBS

CBS

$39.21

1.09 (2.86%)

VIA

Viacom

$26.40

0.87 (3.41%)

VIAB

Viacom

$23.46

0.71 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Conference/Events
Craig-Hallum to hold a conference »

10th Annual Craig-Hallum…

MJARF

MJardin Group

$0.00

(0.00%)

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Hot Stocks
MJardin Group announces partnership with Robes Inc. »

MJardin Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

, SYBX

Synlogic

$2.28

-0.015 (-0.66%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Rubius Therapeutics appoints Maiken Keson-Brookes as CLO »

Rubius Therapeutics…

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

SYBX

Synlogic

$2.28

-0.015 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PBI

Pitney Bowes

$4.95

-0.14 (-2.75%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Pitney Bowes announces partnership with Luxer One »

Pitney Bowes announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.